Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02649907
Other study ID # EA1/143/15
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 12, 2015
Est. completion date May 31, 2021

Study information

Verified date February 2023
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigative trial with aim of 1. the description of the hormonal and metabolic response to meals containing different compositions of macronutrients 2. the metabolic response to these test meals in dependance of the hepatic and muscular insulin sensitivity and abdominal adipose tissue and 3. effects of a weight loss on the hormonal response to these test meals containing different compositions of macronutrients Primary endpoint: Glucagon-like-peptide 1 (GLP-1), Glucose dependent insulinotropic peptide (GIP) and Ghrelin response to a nutritive stimulation characterized by different nutritional composition Secondary endpoints: - differences of substrate utilization depending on the nutritive composition - effects of different hepatic and muscular insulin sensitivity as well as impact of visceral fat mass on the hormonal and metabolic response - effect of weight loss on the hormonal and metabolic response to different test meals Study procedure: After primary characterization 50 probands (male and female) will receive 3 different test meals within a randomised (meal order) controlled trial. The three different test meals differ in nutritional composition. During consumption of the test meal a characterization of the endogenous hormonal response and appetite behaviour is performed. A nutritional counselling is performed according to the guidelines of the German Nutrition Society (DGE) to ensure a stable nutritive behaviour in the three days before the test meal administration. After analysis of the hormonal response to these 3 different testmeals follows a weight reduction period over 3 months. Afterwards reevaluation of the probands (again administration of 3 different test meals over a period of 3 weeks) will be performed. Principal aim of the study: Gain of information leading to the understanding of the hormonal regulation of food intake. The individual variability shall be determined with the aim of an identification of patient groups which show various intensities of the responses to different macronutrients.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date May 31, 2021
Est. primary completion date June 19, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - BMI>27 kg/m2 - given written informed consent Exclusion Criteria: - type 2 diabetes patients treated by insulin or drugs influencing incretin levels - lack of health insurance - weight changes > 5 kg in the past 2 months - pregnancy, breastfeeding - patients with: - severe heart failure - impaired hepatic or renal function - disturbed coagulation (biopsies will not be taken in those subjects) - infection, malabsorption - severe hypertension - cancer within the last 5 years - eating disorders or any other psychiatric condition that would interact with the trial intervention - any other endocrine disorder - changes of smoking habits or diets within the last 3 months prior to study inclusion *other severe chronic diseases

Study Design


Intervention

Dietary Supplement:
nutritional stimulation via different testmeals
nutritional stimulation of hormonal response through different testmeals
Other:
Nutritional counseling
nutritional counseling for healthy eating behaviour
Dietary Supplement:
formula diet
formula diet to help weight loss

Locations

Country Name City State
Germany Charite Campus Mitte Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incretine response to different nutritive stimulations Concentration of GLP-1 after different test meals will be analysed by ELISA before and after weight loss 3 month
Primary Incretine response to different nutritive stimulations Concentration of GIP after different test meals will be analysed by ELISA before and after weight loss 3 month
Primary Incretine response to different nutritive stimulations Concentration of Ghrelin after different test meals will be analysed by ELISA before and after weight loss 3 month
Secondary Correlation of the GLP-1 responses with the reduction of hunger (questionnaire) after a nutritive stimulation by different nutritional components GLP-1 (concentration) will be measured by ELISA, hunger feeling will be measured by questionnaire using a visual analog score (from 1 (less) to 10 (more)) 3 month
Secondary correlation of the GIP responses with the reduction of hunger (questionnaire)after a nutritive stimulation by different nutritional components GIP (concentration) will be measured by ELISA, hunger feeling will be measured by questionnaire using a visual analog score (from 1 (less) to 10 (more)) 3 month
Secondary Correlation of the Ghrelin responses with the reduction of hunger (questionnaire) after a nutritive stimulation by different nutritional components Ghrelin (concentration) will be measured by ELISA, hunger feeling will be measured by questionnaire using a visual analog score (from 1 (less) to 10 (more)) 3 month
Secondary Correlation of the insulin responses with the reduction of hunger (questionnaire) after a nutritive stimulation by different nutritional components insulin (concentration) will be measured by ELISA, hunger feeling will be measured by questionnaire using a visual analog score (from 1 (less) to 10 (more)) 3 month
Secondary -differences of substrate utilization depending on the nutritional composition postprandial thermogenesis will be assessed by indirect caloriemetry 3 month
Secondary -differences of substrate utilization depending on the nutritional composition postprandial glucose concentration (physiological parameter) will be assessed in skeletal muscle and adipose tissue by microdialysis 3 month
Secondary -differences of substrate utilization depending on the nutritional composition postprandial pyruvate concentration (physiological parameter) will be assessed in skeletal muscle and adipose tissue by microdialysis 3 month
Secondary -differences of substrate utilization depending on the nutritional composition postprandial lactate concentration (physiological parameter) will be assessed in skeletal muscle and adipose tissue by microdialysis 3 month
Secondary -differences of lipolysis depending on the nutritional composition postprandial glycerol concentration (physiological parameter) will be assessed by microdialysis 3 month
Secondary -Change of hepatic insulin sensitivity after weight loss hepatic insulin sensitivity assessed via endogenous glucose production measured in mg/kg/min 3 month
Secondary -Change of meal induced GLP-1 concentration during weight loss Concentration of GLP-1 after different test meals will be analysed by ELISA 3 month
Secondary -Change of meal induced GIP concentration during weight loss Concentration of GIP after different test meals will be analysed by ELISA 3 month
Secondary -Change of meal induced Ghrelin concentration during weight loss Concentration of Ghrelin after different test meals will be analysed by ELISA 3 month
Secondary -Weight loss mediated changes of meal induced GLP-1 concentration in insulin resistant vs insulin sensitive subjects Insulin sensitivity assessed via insulin sensitivity index 3 month
Secondary -Weight loss mediated changes of meal induced GIP concentration in insulin resistant vs insulin sensitive subjects Insulin sensitivity assessed via insulin sensitivity index 3 month
Secondary -Weight loss mediated changes of meal induced Ghrelin concentration in insulin resistant vs insulin sensitive subjects Insulin sensitivity assessed via insulin sensitivity index 3 month
Secondary Change of fat distribution after weight loss total fat mass will be assessed 3 month
Secondary Change of fat distribution after weight loss visceral fat mass will be assessed 3 month
Secondary Change of fat distribution after weight loss hepatic fat mass will be assessed 3 month
Secondary Change of skeletal muscle mass after weight loss skeletal muscle mass will be assessed 3 month
Secondary Prediction of weight regain (weight in kilograms and height in meters will be combined to report BMI in kg/m^2). Analysis of the predictive impact of hormones like GLP-1, Ghrelin, GIP and insulin in the context of body weight regain. Linear and logistic regression models will be used to identify predictive biomarkers 12 months
Secondary Prediction of weight regain (weight in kilograms and height in meters will be combined to report BMI in kg/m^2). Analysis of the predictive impact of hormones like GLP-1, Ghrelin, GIP and insulin in the context of insulin sensitivity. Linear and logistic regression models will be used to identify predictive biomarkers 12 months
Secondary Prediction of weight regain (weight in kilograms and height in meters will be combined to report BMI in kg/m^2). Analysis of the predictive impact of hormones like GLP-1, Ghrelin, GIP and insulin in the context of insulin sensitivity. Linear and logistic regression models will be used to identify predictive biomarkers 24 months
Secondary Prediction of weight regain (weight in kilograms and height in meters will be combined to report BMI in kg/m^2). Analysis of the predictive impact of hormones like GLP-1, Ghrelin, GIP and insulin in the context of body weight regain. Linear and logistic regression models will be used to identify predictive biomarkers 24 months
Secondary To analyse the long term course of body weight after 12 month Measurement of body weight after 12 months 12 months
Secondary To analyse the long term course of body weight after 24 month Measurement of body weight after 24 months 24 months
Secondary To analyse the long term course of body weight after 36 month Measurement of body weight after 36 months 36 months
Secondary To analyse the long term course of body weight after 48 month Measurement of body weight after 48 months 48 months
See also
  Status Clinical Trial Phase
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Terminated NCT03316105 - Effect of T6 Dermatome Electrical Stimulation on Gastroduodenal Motility in Healthy Volunteers N/A
Completed NCT03700736 - The Healthy Moms Study: Comparison of a Post-Partum Weight Loss Intervention Delivered Via Facebook or In-Person Groups N/A
Active, not recruiting NCT04353726 - Knowledge-based Dietary Weight Management. N/A
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02877004 - LLLT for Reducing Waste Circumference and Weight N/A
Active, not recruiting NCT04327141 - Low Sugar Protein Pacing, Intermittent Fasting Diet in Men and Women N/A
Completed NCT03929198 - Translation of Pritikin Program to the Community N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Recruiting NCT05942326 - Sleep Goal-focused Online Access to Lifestyle Support N/A
Completed NCT00535600 - Effects of Bariatric Surgery on Insulin
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Active, not recruiting NCT04357119 - Common Limb Length in One-anastomosis Gastric Bypass N/A
Completed NCT02948517 - Time Restricted Feeding for Weight Loss and Cardio-protection N/A
Completed NCT03139760 - POWERSforID: A Telehealth Weight Management System for Adults With Intellectual Disability N/A
Completed NCT02945410 - Effect of Caloric Restriction and Protein Intake on Metabolism and Anabolic Sensitivity N/A
Completed NCT03210207 - Gastric Plication in Mexican Patients N/A
Recruiting NCT02559479 - A Study to Assess the Effect of a Normal vs. High Protein Diets in Carbohydrates Metabolism in Obese Subjects With Diabetes or Prediabetes N/A